(Q41529299)

2 October 2017

1 reference

title

Amiodarone: the expanding antiarrhythmic role and how to follow a patient on chronic therapy (English)

1 reference

2 October 2017

1 reference

B N Singh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

15 May 2020

language of work or name

English

0 references

publication date

1 July 1997

1 reference

2 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

15 May 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

15 May 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

15 May 2020

page(s)

608-618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

Amiodarone in refractory life-threatening ventricular arrhythmias

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

Amiodarone and post-MI patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

Low-dose amiodarone for atrial fibrillation: time for a prospective study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

Therapy of Sustained Ventricular Arrhythmias With Amiodarone: Prediction of Efficacy With Serial Electrophysiologic Studies

21 January 2018

1 reference

12 December 2020

Effect of amiodarone on mortality after myocardial infarction: a double-blind, placebo-controlled, pilot study

1 reference

12 December 2020

The amiodarone odyssey

1 reference

12 December 2020

Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study

1 reference

12 December 2020

The historical development, cellular electrophysiology and pharmacology of amiodarone

1 reference

12 December 2020

Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation

1 reference

12 December 2020

Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment

1 reference

12 December 2020

Evolution of the management of malignant ventricular tachyarrhythmias: the roles of drug therapy and implantable defibrillators

1 reference

12 December 2020

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

12 December 2020

Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter.

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Implantable cardioverter-defibrillators: not the ultimate gold standard for gauging therapy of VT/fibrillation

1 reference

12 December 2020

Implantable cardioverter-defibrillator. Lifesaver or a device looking for a disease?

1 reference

12 December 2020

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

1 reference

12 December 2020

Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators

1 reference

12 December 2020

The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators

1 reference

12 December 2020

Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators

1 reference

12 December 2020

Five-year follow-up of 589 patients treated with amiodarone

1 reference

12 December 2020

Expanding indications for the use of Class III agents in patients at high risk for sudden death

1 reference

12 December 2020

Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

12 December 2020

Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators

1 reference

12 December 2020

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

12 December 2020

Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators

1 reference

12 December 2020

Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

7 January 2021

inferred from DOI database lookup

Antiarrhythmic drugs and polyneuropathy. The Collaborative Group for the Study of Polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960200706

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4960200706

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6656071&resulttype=core&format=json

15 May 2020

9220176

1 reference